Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Germ Cell and Embryonal × Erlotinib Hydrochloride × 30 days × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Papillary renal cell carcinoma, sporadic 1 Pancreatic Intraductal Neoplasms 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Hereditary leiomyomatosis and renal cell cancer 1 Carcinoma, Renal Cell 1 Adult Solid Neoplasm 1

Interventions

Etoposide 2 Cyclophosphamide 2 Cisplatin 2 Carboplatin 2 pralsetinib 1 pembrolizumab 1 fludarabine phosphate 1 fludarabine 1 etoposide phosphate 1 Standard of Care 1 Specimen Handling 1 Sirolimus 1 Respiratory Physiological Phenomena 1 Practice Guidelines as Topic 1 Platinum 1 Pemetrexed 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Gemcitabine 1 Celecoxib 1 Bleomycin 1 Biopsy 1 130-nm albumin-bound paclitaxel 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡